While genomic profiling did not reveal a particular interest in MT4-MMP, immunohistochemistry studies have demonstrated its overexpression in breast cancers, suggesting possible alternative splicing in MT4-MMP transcripts in human cancers. This evidence concerns the gene MT4 and breast cancer.